Skip to main content

Table 12 The mean lifetime attributed cancer mortality risks due to whole lung low dose radiotherapy (with a prescribed dose equal to 1 Gy) in VMAT technique for adult male and female patients at different ages

From: Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia

 

Age at exposure time (years)

20

30

40

50

60

70

80

Male

Stomach

0.095

0.072

0.068

0.059

0.050

0.036

0.018

Liver

0.131

0.091

0.091

0.080

0.068

0.046

0.023

Lung

1.661

1.177

1.177

1.144

1.023

0.781

0.462

Other

0.208

0.146

0.136

0.119

0.090

0.056

0.026

All solids

2.094

1.486

1.472

1.402

1.231

0.918

0.529

Female

Stomach

0.131

0.095

0.090

0.086

0.072

0.059

0.036

Liver

0.068

0.051

0.046

0.046

0.040

0.029

0.017

Lung

3.355

2.343

2.332

2.244

2.013

1.540

0.891

Breast

0.596

0.360

0.207

0.112

0.053

0.030

0.012

Other

0.228

0.160

0.150

0.133

0.107

0.073

0.037

All solids

4.378

3.008

2.824

2.621

2.285

1.729

0.993

  1. Risk values are presented as incidence probability per 100 individuals